Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMEM97 | Q5BJF2 | 6/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | PTGDR2 | Q9Y5Y4 | 8/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13382410 | 0.83 | TMEM97 (0.46) | TMEM97SIGMAR1MEN1KMT2ANPSR1 | |
| SCHEMBL4399041 | 0.82 | TMEM97 (0.45) | TMEM97SIGMAR1MEN1KMT2ANPSR1 | |
| SCHEMBL7103546 | 0.78 | TMEM97 (0.42) | TMEM97SIGMAR1PTGDR2SMN1; SMN2L3MBTL1 | |
| SCHEMBL6160274 | 0.77 | TMEM97 (0.60) | TMEM97SIGMAR1PTGDR2 | |
| SCHEMBL749417 | 0.75 | GRM5 (0.49) | TMEM97SIGMAR1MEN1KMT2ANPSR1 | |
| SCHEMBL31119634 | 0.75 | HTT (0.43) | TMEM97SIGMAR1MEN1KMT2ANPSR1 | |
| SCHEMBL7197953 | 0.74 | TMEM97 (0.39) | TMEM97SIGMAR1MEN1KMT2ANPSR1 | |
| SCHEMBL18767256 | 0.74 | RAB9A (0.43) | TMEM97SIGMAR1MEN1KMT2ANPSR1 | |
| SCHEMBL30421695 | 0.74 | PTGDR2 (0.45) | PTGDR2DHFR | |
| SCHEMBL21315051 | 0.74 | TMEM97 (0.43) | TMEM97SIGMAR1MEN1KMT2APTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210323987-A1 | Methods for the Synthesis of Heteroatom Containing Polycyclic Aromatic Hydrocarbons | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323987-A1 | Methods for the Synthesis of Heteroatom Containing Polycyclic Aromatic Hydrocarbons | AHR, PAH, ALKBH3 | TMEM97 4861/4885SIGMAR1 3343/4885MEN1 1721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.